Skip to main content
. Author manuscript; available in PMC: 2018 Sep 1.
Published in final edited form as: Healthc (Amst). 2016 Dec 5;5(3):105–111. doi: 10.1016/j.hjdsi.2016.11.001

Table 2.

Estimated prevalence of HCV infected patients in Pennsylvania Medicaid in 2007–2015 and the number of new episodes of decompensated cirrhosis, hepatocellular carcinoma, and liver transplant.

Year HCV cases in
Claims data*
Model-based HCV-infected population in Medicaid

Total with
diagnoses
Total
aware
Total DC
incidence
HCC
incidence
Liver
transplants
2001 - 19,700 50,000 50 57 12
2002 - 19,600 50,000 40 43 14
2003 - 19,600 50,000 56 51 11
2004 - 19,500 49,800 70 59 9
2005 - 19,700 50,200 81 49 10
2006 - 19,900 50,000 94 57 11
2007 18,955 20,400 49,500 101 60 12
2008 20,242 21,800 50,800 111 65 11
2009 23,234 22,800 50,400 120 66 12
2010 24,352 24,000 50,200 129 70 13
2011 26,061 25,400 49,900 141 79 14
2012 26,432 26,700 49,500 149 83 14
2013 - 28,500 48,400 143 84 15
2014 - 30,100 47,700 139 86 15
2015 31,200 46,700 108 78 16

Source: Simulation model results

*

The numbers of HCV cases identified from claims data are included for comparison in the highlighted column.

The model-based results for each year indicate values at the end of the calendar year.

Abbreviations: HCV = hepatitis C virus; DC = decompensated cirrhosis; HCC = hepatocellular carcinoma.